Calcium Channel Blockers Induced Gingival Overgrowth: A Comprehensive Review from a Dental Perspective
- PMID: 35966914
- PMCID: PMC9369783
- DOI: 10.4103/jispcd.JISPCD_57_22
Calcium Channel Blockers Induced Gingival Overgrowth: A Comprehensive Review from a Dental Perspective
Abstract
Background: Gingival overgrowth (GO) as a manifestation of calcium channel blockers (CCBs) was first introduced in the literature by Ramon et al. in 1984. Since then, the use of CCBs as a treatment modality for hypertension has been recorded extensively in the literature for its association with GO.
Aim: The aim of our study is to evaluate histopathology, treatment, and follow-up for the cases detailed in various studies and also to highlight the protocol mentioned to identify these presentations.
Materials and methods: A broad search was conducted from the period 1980 to 2021 using electronic databases PubMed Central, Scopus, Cochrane, and SciELO databases. About 293 articles were initially chosen. The articles further excluded did not fit the criteria for the study and eventually 50 articles which met the inclusion criteria were chosen as part of this literature review.
Results: A comparative analysis was carried out regarding histopathology, treatment modalities, drug dosage, and duration to evaluate the differences in cases between 1980 and 2021. From the available studies, it was found that the histopathological and clinical findings were varied. Treatment strategies employed were different, though follow-ups in most cases were uniform.
Conclusion: CCBs and their relationship with GO have been widely reported in the literature. Dentists should approach this condition by taking appropriate medical and dental history and follow evidence-based treatment guidelines to provide more relevant and judicious management of this condition. Inter-disciplinary treatment approaches would provide better outcomes.
Keywords: Amlodipine; calcium channel blockers; drug-induced; gingival overgrowth; nifedipine.
Copyright: © 2022 Journal of International Society of Preventive and Community Dentistry.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Influence of 3 calcium channel blockers on gingival overgrowth in a population of severe refractory hypertensive patients.J Periodontal Res. 2018 Oct;53(5):721-726. doi: 10.1111/jre.12556. Epub 2018 Apr 23. J Periodontal Res. 2018. PMID: 29687449
-
Is dental plaque the only etiological factor in Amlodipine induced gingival overgrowth? A systematic review of evidence.J Clin Exp Dent. 2018 Jun 1;10(6):e610-e619. doi: 10.4317/jced.54715. eCollection 2018 Jun. J Clin Exp Dent. 2018. PMID: 29930781 Free PMC article. Review.
-
Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs.J Clin Periodontol. 2015 Jul;42(7):640-6. doi: 10.1111/jcpe.12426. Epub 2015 Jul 14. J Clin Periodontol. 2015. PMID: 26076712
-
Prevalence of gingival enlargement secondary to calcium channel blockers in patients with cardiovascular diseases.J Indian Soc Periodontol. 2012 Jul;16(3):430-5. doi: 10.4103/0972-124X.100925. J Indian Soc Periodontol. 2012. Retraction in: J Indian Soc Periodontol. 2012 Oct;16(4):vi. PMID: 23162342 Free PMC article. Retracted.
-
Calcium channel blockers and gingival overgrowth.Br Dent J. 1991 May 25;170(10):376-9. doi: 10.1038/sj.bdj.4807564. Br Dent J. 1991. PMID: 2064860 Review.
Cited by
-
Novel Insights into Amlodipine-Induced Gingival Enlargement: A Clinical and Molecular Perspective.Pharmaceuticals (Basel). 2024 Aug 16;17(8):1075. doi: 10.3390/ph17081075. Pharmaceuticals (Basel). 2024. PMID: 39204180 Free PMC article.
-
Association of the severity and progression rate of periodontitis with systemic medication intake.Front Oral Health. 2024 Aug 2;5:1447019. doi: 10.3389/froh.2024.1447019. eCollection 2024. Front Oral Health. 2024. PMID: 39157205 Free PMC article.
-
Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system.Front Cardiovasc Med. 2025 May 6;12:1504671. doi: 10.3389/fcvm.2025.1504671. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40395720 Free PMC article.
-
Nifedipine-Influenced Enlargement of the Masticatory Mucosa in an Elderly Edentulous Patient: A Rare Case Report with a Two-Year Follow-Up.Case Rep Dent. 2024 Mar 28;2024:6889574. doi: 10.1155/2024/6889574. eCollection 2024. Case Rep Dent. 2024. PMID: 38576511 Free PMC article.
-
Gingival overgrowth approached using recent mechanical and laser technologies: A case report.Exp Ther Med. 2024 Jan 8;27(2):84. doi: 10.3892/etm.2024.12374. eCollection 2024 Feb. Exp Ther Med. 2024. PMID: 38274335 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous